Need help choosing the right HIPAA software?
Tell us about your practice and we'll recommend the best tools for you.
Prescription digital therapeutic for substance use disorder
Digital mental health support for young people and adults
reSET is a prescription digital therapeutic that delivers a 12-week course of cognitive behavioral therapy with contingency management through a smartphone app, as an adjunct to outpatient treatment for substance use disorder in adults. It was developed by Pear Therapeutics and in 2017 became the first prescription digital therapeutic authorized by the FDA, through the De Novo pathway. Pear Therapeutics filed for Chapter 11 bankruptcy in April 2023 and its assets were sold at auction, but reSET itself is still sold and supported today: PursueCare relaunched it as RESET in October 2024, and XRHealth acquired PursueCare, including RESET and RESET-O, in November 2026.
Kooth plc is a UK based digital mental health provider whose platforms (Kooth, Qwell, and Soluna) combine self guided tools, moderated peer communities, and professional counselling and coaching. In the United States its flagship product is Soluna, a free app for ages 13 to 25 funded by the California Department of Health Care Services, with additional state contracts in New Jersey and Michigan.
Need help choosing the right HIPAA software?
Tell us about your practice and we'll recommend the best tools for you.